Executive Summary

4.2 USD Billion in 2025, the GLP-1 Friendly Foods & Beverages Market is expected to grow at a CAGR of 14.8% to reach 16.7 USD Billion by 2035. The shift spans 2025-2035, moving the category from pharmacy-adjacent SKUs into mainstream retail.

GLP-1 medication users need concentrated protein to offset lean-muscle loss during rapid weight reduction, and appetite suppression is shrinking meal sizes toward single-serve, nutrient-dense formats. India’s draft Front-of-Pack Nutrition Rating amendment is pushing formulators toward verifiable protein and sugar claims.

North America held 42.0% of the market in 2025, ahead of Europe at 28.0% and Asia Pacific at 20.0%. High-Protein Meals lead product demand, as formulators prioritize preserving lean muscle mass among GLP-1 users.

Gastrointestinal side-effect management and single-serve packaging raise costs relative to standard snack formats, pressuring margins for smaller entrants as established food and beverage manufacturers extend protein and hydration lines into the category.

Key Takeaways

• Valued at USD 4.2 Billion in 2025, rising to USD 16.7 Billion by 2035 at a 14.8% CAGR.
• High-Protein Meals lead the By Product Type segmentation axis globally.
• Hydration & Electrolyte Products are an emerging format addressing GLP-1-related gastrointestinal side effects.
• North America held 42.0% share in 2025, ahead of Europe’s 28.0%.
• Muscle-preservation needs among GLP-1 users are the primary demand driver.
• Reformulation and packaging costs weigh heaviest on smaller category entrants.

Market Definition and Scope

The GLP-1 Friendly Foods & Beverages Market comprises packaged foods and beverages formulated for consumers on GLP-1 receptor agonist therapy, spanning high-protein meals, low-sugar snacks, muscle-support beverages and hydration and electrolyte products, positioned around high-protein, portion-controlled and nutrient-dense claims and sold through grocery, specialty nutrition and e-commerce channels.

Prescription GLP-1 medications and medical nutrition therapy products requiring clinical supervision sit outside the boundary; general weight-management snacks without protein-density, portion-control or electrolyte formulation basis are excluded as well.

Market Trends

Muscle-preservation formulation is pulling protein content into mainstream snack formats

Protein fortification is moving from sports-nutrition aisles into everyday meals, snacks and shakes as GLP-1 medication users eat less often but need more protein per meal to protect lean muscle mass. Whey, plant, collagen and egg protein sources anchor reformulated bars, frozen meals and RTD shakes. Mainstream food manufacturers and specialty nutrition brands are absorbing the shift, and demand for High-Protein Meals and Muscle-Support Beverages is expected to broaden beyond current GLP-1 users toward general portion-conscious shoppers through 2035.

Electrolyte and hydration products are emerging as a distinct GLP-1-adjacent category

Hydration and electrolyte products, previously confined to sports nutrition, are gaining a distinct role addressing dehydration and gastrointestinal side effects common to GLP-1 therapy. Electrolyte drinks, powders, tablets and hydration gels are being reformulated and repositioned around this use case rather than athletic performance. Beverage brands and pharmacy-adjacent retailers are extending electrolyte lines accordingly, and the format is expected to grow from a niche adjacency into a core segment of the category by 2035.

Front-of-pack labelling scrutiny is pushing formulators toward verifiable protein and sugar claims

Regulatory scrutiny of nutrition claims is tightening as GLP-1-linked products multiply on shelf. India’s draft Food Safety and Standards Front-of-Pack Nutrition Rating amendment would place a five-star rating near the brand name on packaged foods, rating nutritional profile directly. Formulators serving GLP-1-adjacent consumers are firming up protein, fiber and sugar substantiation on pack, and verifiable claims are becoming a listing requirement rather than a marketing differentiator through the forecast period.

Growth Drivers and Restraints

Muscle-preservation needs are pulling protein density into everyday formats

GLP-1 receptor agonists suppress appetite and cut meal frequency, so each eating occasion must carry more usable protein to limit lean-muscle loss during rapid weight reduction. That mechanism is pulling protein density into frozen, refrigerated and shelf-stable meals and RTD shakes built on whey, casein, plant and collagen sources. Mainstream manufacturers are reformulating existing lines rather than launching standalone medical products, and High-Protein Meals and Muscle-Support Beverages absorb most of this activity as GLP-1 prescribing broadens.

Appetite suppression is shrinking portion sizes toward single-serve formats

Reduced food intake is shifting purchases toward single-serve, portion-controlled formats over family-size packaging, since smaller, less frequent meals leave little room for leftovers. Single-serve snacks, meal-replacement bars and shakes, and portion-controlled meal kits absorb this shift directly, alongside Nutrient-Dense & Fortified products that concentrate vitamins and minerals into smaller servings. Snack manufacturers are resizing existing bar and salty-snack lines downward, and retailers are adding smaller pack sizes to shelf sets through the forecast period.

Front-of-pack labelling scrutiny is raising the bar for verifiable claims

Regulatory attention to on-pack nutrition claims is tightening as GLP-1-adjacent products multiply on shelf. India’s draft Food Safety and Standards (Labelling and Display) Amendment Regulations would place a five-star Indian Nutrition Rating near the brand name, scoring nutritional profile directly rather than leaving protein and sugar content to marketing copy; it remains unnotified more than three years after drafting, but the direction is toward substantiated, front-of-pack disclosure. Formulators are firming up protein and sugar substantiation on pack, raising compliance cost for smaller entrants.

Reformulation and single-serve packaging raise cost structures across the category

Concentrating protein and micronutrients into smaller servings raises input cost per unit relative to standard snack and meal formats, and single-serve packaging adds material and line-changeover cost that family-size formats avoid. Smaller snack and beverage entrants without existing protein-sourcing or co-packing relationships absorb this pressure most directly, while established manufacturers spread it across broader existing protein and hydration portfolios extended into the category.

Shelf-space competition limits how quickly new entrants reach retail

Retail listing costs and finite shelf space slow the pace at which new GLP-1-adjacent brands reach grocery and specialty channels, since retailers favor established protein and snack suppliers with existing distribution relationships over unproven entrants. Direct-to-consumer and e-commerce channels absorb the overflow, giving newer brands a route to market ahead of physical retail listing, but that path carries its own customer-acquisition cost that limits scale.

Segment Analysis

By Product Type

• High-Protein Meals (largest) – Prepared or packaged meals formulated with elevated protein content to help preserve lean muscle mass during appetite-suppressed eating on GLP-1 therapy

• Frozen Meals
• Refrigerated Meals
• Meal Kits
• Shelf-Stable Meals
• Low-Sugar Snacks – Packaged snack foods reformulated with reduced or alternative sweeteners to fit the smaller, less frequent eating patterns of GLP-1 medication users

• Bars
• Salty Snacks
• Baked Snacks & Cookies
• Meat Snacks
• Nuts & Trail Mixes
• Muscle-Support Beverages – Ready-to-drink shakes or powders combining protein and amino acids marketed to offset muscle loss associated with rapid GLP-1-induced weight reduction
• RTD Protein Shakes

• Dairy-Based
• Plant-Based
• Protein Powders

• Whey Protein
• Casein Protein
• Plant-Based Protein
• Collagen Protein

• Protein Water
• Protein Coffee & Creamers
• Hydration & Electrolyte Products – Drinks, powders, or tablets delivering fluids and minerals such as sodium and potassium to counter dehydration and gastrointestinal side effects from GLP-1 drugs

• Electrolyte Drinks (RTD)
• Electrolyte Powders & Mixes
• Electrolyte Tablets
• Hydration Gels & Chews

High-Protein Meals lead the product-type axis in 2025, ahead of Low-Sugar Snacks, Muscle-Support Beverages and Hydration & Electrolyte Products. GLP-1 therapy sharply reduces meal frequency and appetite, so shoppers gravitate toward frozen, refrigerated and shelf-stable meals engineered to deliver a fixed protein dose per sitting, protecting lean muscle mass without requiring separate supplementation. Dietitian-authored eating guidance issued alongside GLP-1 prescriptions reinforces the format, since a single packaged meal is easier to follow consistently than assembling protein from several dishes. Muscle-Support Beverages are growing fastest. Ready-to-drink protein shakes and protein waters are substituting for solid snacking occasions that GLP-1 users can no longer tolerate comfortably, and the liquid format suits patients managing nausea or early satiety while still needing to hit a daily protein target.

By Nutritional Positioning

• High Protein (largest) – Foods and beverages formulated with elevated protein content, often from whey, plant, or collagen sources, to help preserve lean muscle mass during weight loss
• Whey Protein-Based

• Whey Protein Concentrate
• Whey Protein Isolate
• Whey Protein Hydrolysate

• Plant Protein-Based
• Collagen-Based
• Egg Protein-Based
• High Fiber – Products containing added or naturally concentrated dietary fiber, such as inulin or psyllium, intended to slow digestion and prolong feelings of fullness

• Soluble Fiber
• Insoluble Fiber
• Prebiotic Fiber
• Low/Reduced Sugar – Items reformulated with less added sugar or sweetened with non-nutritive or reduced-calorie substitutes to lower overall sugar content

• No Added Sugar
• Reduced Sugar
• Sugar-Free/Zero Sugar

• Stevia-Sweetened
• Monk Fruit-Sweetened
• Allulose-Sweetened
• Portion-Controlled – Pre-measured single-serving foods or beverages packaged to help consumers manage smaller appetites and avoid overeating

• Single-Serve Snacks
• Meal Replacement Bars
• Meal Replacement Shakes
• Portion-Controlled Meal Kits
• Nutrient-Dense & Fortified – Foods enriched with added vitamins, minerals, or micronutrients to offset reduced nutrient intake that can accompany appetite suppression

• Vitamin & Mineral-Fortified
• Probiotic/Prebiotic-Fortified
• Electrolyte-Fortified
• Metabolic Support – Foods and beverages formulated with ingredients such as chromium, berberine, or specific fibers intended to influence blood sugar or insulin response

• Blood Sugar Management
• Muscle Preservation Support
• Satiety & Appetite Control
• Gut Health & Microbiome Support
• Electrolyte & Hydration Support

High Protein is the leading nutritional positioning in 2025, ahead of High Fiber, Low/Reduced Sugar, Portion-Controlled, Nutrient-Dense & Fortified and Metabolic Support. Protein retention is the clinical priority during GLP-1-induced weight loss, and whey, plant and collagen formulations let brands make a direct, easily labeled claim against muscle preservation that resonates with prescribing physicians and patients alike. Metabolic Support is the fastest-growing positioning. Formulations built around chromium, berberine and specific fiber blends are being adopted as consumers move past generic protein claims toward products marketed to work alongside GLP-1 pharmacology on blood sugar and satiety, and brands are folding these ingredients into existing high-protein lines rather than launching separate product families.

Regional Analysis

North America holds 42.0% of the GLP-1 friendly foods and beverages market in 2025, the largest of the three regions tracked. Reformulation decisions are increasingly shaped by the FDA’s proposed Front-of-Package Nutrition Information rule, which would require a %DV box for saturated fat, sodium and added sugars on most packaged foods, and by FTC scrutiny of health-claim substantiation on GLP-1-adjacent marketing. Brands selling high-protein meals and low-sugar snacks into US retail are rewriting the ingredient deck and adjusting serving sizes ahead of the rule, since a poor front-of-pack rating undermines share of shelf against competing GLP-1-adjacent listings.

Europe accounts for 28.0% of the market in 2025, the second-largest region. Danone S.A., headquartered in France, has repositioned parts of its high-protein and fortified dairy portfolio toward the GLP-1 consumer, with satiety and protein-content health claims held to the substantiation standard set by EFSA under EU Regulation 1924/2006. Fragmented national retail structures across the region mean listing decisions and price-pack architecture run country by country, so pan-European scale depends on winning share of shelf chain by chain rather than through a single gateway.

Asia Pacific holds 20.0% of the market in 2025. India’s National Institute of Nutrition has long tracked protein intake shortfalls across the population, a gap that packaged high-protein and portion-controlled products are now positioned to close as GLP-1 prescriptions expand in urban centers, with FSSAI labelling rules governing how those products state their nutrition and health claims. Social and live-commerce channels in China are becoming a primary discovery route for these products, compressing the purchase frequency cycle relative to the region’s more store-led markets, and pulling smaller challenger brands into the category faster than traditional retail listings allow.

Competitive Landscape

The market is led by a group of established packaged-food and beverage manufacturers rather than by GLP-1-focused specialists: Conagra Brands, Nestlé S.A., Kraft Heinz, General Mills, PepsiCo, The Coca-Cola Company, Danone S.A., Kellanova, Post Holdings and BellRing Brands. Competition centers on brand equity built over decades of mainstream distribution, innovation and launch cadence in reformulating existing snack and beverage lines toward higher protein and lower sugar, and breadth of retail distribution that lets a repositioned product reach shelf faster than a challenger brand can. Supply-chain cost position also matters, since whey and plant-protein sourcing costs shape price-pack architecture at mass-tier price points. BellRing Brands and Post Holdings compete primarily on protein-beverage and shake formats, while Conagra, Kraft Heinz and General Mills lean on reformulating frozen and shelf-stable meal portfolios that already carry national distribution. PepsiCo and The Coca-Cola Company are extending protein and electrolyte lines from existing beverage infrastructure rather than building new production capacity. E-commerce execution is becoming a secondary basis of competition, since GLP-1 patients increasingly discover reformulated products through telehealth-linked retail partnerships rather than in-store browsing.

Strategic Outlook

The clearest whitespace is Metabolic Support positioning sold through liquid and portion-controlled formats, benefiting challenger beverage brands able to move faster than diversified food manufacturers. Materializing at scale depends on GLP-1 prescription volumes expanding beyond specialty pharmacy into mainstream retail pharmacy, widening the addressable patient base past today’s early adopters.

By 2035, competitive weight is expected to shift from broad high-protein claims toward formulations tied to specific GLP-1 effects, muscle preservation, satiety and hydration, with portion control becoming a default packaging format rather than a premium feature.

GLP-1 Friendly Foods & Beverages Market Report Scope

Frequently Asked Questions

How big is the GLP-1 Friendly Foods & Beverages Market?

The GLP-1 Friendly Foods & Beverages Market was valued at USD 4.2 Billion in 2025. This base-year figure covers high-protein meals, low-sugar snacks, muscle-support beverages and hydration and electrolyte products formulated for consumers on GLP-1 therapy. Category tracking begins in 2020.

What is the growth forecast for the GLP-1 Friendly Foods & Beverages Market?

The market is projected to reach USD 16.7 Billion by 2035, up from USD 4.2 Billion in 2025, expanding at a 14.8% CAGR across 2025-2035. Growth through the period tracks how quickly GLP-1 prescriptions and adjacent nutrition products move into mainstream retail channels.

Which region holds the largest share of the GLP-1 Friendly Foods & Beverages Market?

North America held 42.0% of the GLP-1 Friendly Foods & Beverages Market in 2025. The share reflects the region’s early, concentrated uptake of GLP-1 prescriptions alongside an established packaged-food and supplement retail base positioned to reformulate quickly around new dietary patterns.

Which region is growing fastest in the GLP-1 Friendly Foods & Beverages Market?

Asia Pacific is expected to expand fastest among the tracked regions through 2035. The region held a 20.0% share in 2025, the smallest of the three, leaving more headroom as GLP-1 therapy access and modern nutrition retail broaden across its population base.

Which segment leads the GLP-1 Friendly Foods & Beverages Market?

High-Protein Meals lead the GLP-1 Friendly Foods & Beverages Market by product type. Frozen, refrigerated, meal-kit and shelf-stable formats built with elevated protein content help preserve lean muscle mass through the appetite-suppressed eating patterns common among GLP-1 medication users.

What is driving growth in the GLP-1 Friendly Foods & Beverages Market?

GLP-1 prescription growth and demand for nutrient-dense, portion-controlled products are the two primary drivers behind category expansion. As appetite-suppressed patients eat less overall, food and beverage brands are reformulating toward concentrated protein and fiber content to fit smaller meal volumes.

Who are the key players in the GLP-1 Friendly Foods & Beverages Market?

Conagra Brands, Nestlé S.A., Kraft Heinz, General Mills, PepsiCo, The Coca-Cola Company, Danone S.A. and Kellanova lead the GLP-1 Friendly Foods & Beverages Market. Packaged-food majors and protein-nutrition specialists are competing for shelf space and retail-media placement as the category scales.

Which nutritional positioning leads the GLP-1 Friendly Foods & Beverages Market?

High Protein is the leading nutritional positioning in the GLP-1 Friendly Foods & Beverages Market. Whey, plant and collagen-based formulations dominate this positioning because elevated protein content directly addresses the lean-muscle loss associated with rapid, appetite-suppressed weight reduction under GLP-1 therapy.